Latest news with #DorisWong
Business Upturn
6 days ago
- Business
- Business Upturn
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
By GlobeNewswire Published on June 4, 2025, 01:15 IST KUALA LUMPUR, MALAYSIA, June 03, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel' or the 'Company'), a biopharmaceutical company that develops innovative cancer medicine, today announced that it has received a letter (the 'Compliance Notice') from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ('Nasdaq') dated June 3, 2025, informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the 'Minimum Bid Price Requirement'). As previously announced, Cyclacel received a notification letter from Nasdaq dated December 6, 2024, indicating that its shares of common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of Nasdaq. According to the Compliance Notice, since then, Nasdaq has determined that for 15 consecutive business days, from May 12, 2025 to June 2, 2025, the closing bid price of the Company's shares of common stock has been at $1.00 per share or greater, and accordingly the Company has regained compliance with the Minimum Bid Price Requirement and the matter is closed. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit For further information contact: Cyclacel Pharmaceuticals, Dr. Doris Wong Chief Executive Officer Email: [email protected] Forward-looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Safe Harbor provisions of the US Private Securities Litigation Reform Act of 1995, and encompasses all statements, other than statements of historical fact contained in this press release. These forward-looking statements can be identified by terminology such as 'may,' 'could,' 'will,' 'expects,' 'anticipates,' 'aims,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'targets,' 'likely to', 'understands' and similar statements. These forward-looking statements are based on management's current expectations. However, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors and circumstances that may cause Cyclacel's actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including conditions in the U.S. capital markets, negative global economic conditions, potential negative developments resulting from epidemics or natural disasters, other negative developments in Cyclacel's business or unfavorable legislative or regulatory developments. We caution you therefore against relying on these forward-looking statements, and we qualify all of our forward-looking statements by these cautionary statements. For a discussion of additional factors that may affect the outcome of such forward-looking statements, see our 2024 annual report filed with the SEC on Form 10-K on April 2, 2025, and in particular the 'Risk Factors' section, as well as the other documents filed with or furnished to the SEC by Cyclacel from time to time. Copies of these filings are available online from the SEC at or on the SEC Filings section of our Investor Relations website at These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. These forward-looking statements should not be relied upon as representing Cyclacel's views as of any date subsequent to the date of this press release. All forward-looking statements in this press release are based on information currently available to Cyclacel, and Cyclacel and its authorized representatives assume no obligation to update these forward-looking statements in light of new information or future events. Accordingly, undue reliance should not be placed upon the forward-looking statements. © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
South China Morning Post
07-03-2025
- Entertainment
- South China Morning Post
5 of the best things to do in Hong Kong this weekend, March 7-9, such as guided meditation
With early March bringing a chilly touch and the promise of a rainy weekend to Hong Kong, it may be tempting to throw your plans out of the window and stay at home. Advertisement However, the city offers a mix of cosy and engaging activities this weekend to draw you outside – head to a gallery for a thought-provoking art exhibition, celebrate International Women's Day with empowering cocktail creations, or watch a science fiction film from an Oscar-winning director. Though the skies may be grey, we hope our suggestions for a fulfilling weekend provide a silver lining. 1. Adrian Wong X Doris Wong: The Trivial Sublime Two artists take the meaning of life and the act of caring for yourself and others as starting points for their joint exhibition at SC Gallery in Wong Chuk Hang, on Hong Kong Island. Doris Wong Wai-yin , an art historian and multimedia artist, is showing work created through 'Pastel Nagomi Art' – a type of healing art that forces slow, focused creation to relax and de-stress. Her works make references to art history and explore themes of motherhood and nurture. Meanwhile, Adrian Wong combines his deadpan humour with the stress of juggling multiple roles as father, professor and artist in his works, which are inspired by his interactions with his children. Advertisement Adrian Wong X Doris Wong: The Trivial Sublime, SC Gallery, 1902, Sungib Industrial Centre, 53 Wong Chuk Hang Road, Wong Chuk Hang, Tuesday-Saturday, 11.30am-6.30pm. Until April 5.
